Was then readmitted from [**Date range (3) 86064**], still on vanc/meropenem, again for PNA, with mini-BAL culture at time positive for pseudomonas resistant to meropenem and cefepime.
Patient treated with tobramycin and ceftazadime for planned 21 day course (starting [**2130-12-5**]), and was followed by ID in outpatient setting following discharge.
Has been off predinsone for his obstructive lung disease since [**Month (only) 1096**], but states he has still been on bactrim daily.
Patient was given cefepime and levaquin and a 500cc bolus of NS, and admitted to ICU for further evaluation and management.
Rhinorrhea and nasal congestion.
Hajdu-[**Location (un) 2987**] Syndrome (rare autosomal dominant congenital connective tissue disorder characterized by severe and excessive  bone resorption leading to osteoporosis, also known as type VI idiopathic osteolysis) 2.
CV: RRR, normal S1 + S2, no murmurs, rubs, gallops Abdomen: bowel sounds present, soft, non-tender, non-distended, no rebound tenderness or guarding, no organomegaly Ext: warm, well perfused, 2+ radial/PT/DP pulses, no edema, mild tenderness to palpation over medial left knee joint though knee without any erythema, warmth, or fluid Skin: scattered excoriations on left arm and back, warm, right olecranon ulcer healed Neuro: AAOx3, CN 2-12 grossly intact, moving all four extremities Psych: calm, appropriate  Pertinent Results: ADMISSION LABS: [**2130-4-14**] 09:50AM BLOOD WBC-5.7 RBC-3.94* Hgb-10.3* Hct-31.6* MCV-80* MCH-26.2* MCHC-32.7 RDW-14.7 Plt Ct-165 [**2130-4-14**] 09:50AM BLOOD Glucose-126* UreaN-23* Creat-0.6 Na-137 K-4.8 Cl-97 HCO3-32 AnGap-13 [**2130-4-14**] 09:50AM BLOOD CK(CPK)-220 [**2130-4-14**] 09:50AM BLOOD Lipase-22 [**2130-4-14**] 09:50AM BLOOD CK-MB-3 cTropnT-<0.01 [**2130-4-14**] 09:50AM BLOOD Calcium-9.6 Phos-4.3 Mg-2.0 [**2130-4-14**] 09:59AM BLOOD Glucose-126* Lactate-1.0 Na-138 K-4.2 Cl-92* calHCO3-33* .
Midline tracheostomy tube is again noted.
He has been on oral bactrim for prophylaxis, and was most recently treated [**11/2129**]/[**2129**] with ceftazidime and tobramycin due to resistance pattern of pseudomonas.
Case discussed with ID service, and given patient's previous culture data and resistance patterns, recommended broad treatment with vanco/tobra/ceftaz pending new culture data.
Patient's respiratory status slowly improved with antibiotic therapy, and patient was back to baseline O2 requirements at time of discharge.
Had PICC placed, and will continue on tobramycin and ceftazidime to complete a 3-week course ([**Date range (1) 86066**]).
He has home VNA to assist with antibiotic administration.
He will have twice-weekly CBC, BUN/Cr, and LFTs and once-weekly tobramycin troughs with results faxed to the [**Hospital **] clinic.
Has also recently been on chronic prednisone for an element of obstructive lung disease, though per his report he has been off prednisone since [**31**]/[**2129**].
As above, he was on albuterol/ipratropium nebs Q6H prn SOB/wheezing.
Also continued home Montelukast 10mg PO daily.
Chest pain resolved with treatment of pneumonia.
# HAJDU-[**Location (un) **] SYNDROME: He is currently being treated with methadone 50mg and morphine for diffuse painful bony deformities.
Patient continued on outpatient regimen of methadone 50mg TID, with morphine prn pain.
Patient also continued on baclofen, gabapentin, calcium, and vitamin D3.
Monitored and continued ferrous sulfate daily.
Ferrous sulfate 350mg [**Hospital1 **] 3.
Methadone 50mg PO TID 4.
Albuterol nebs q6h 5.
Ipratropium nebs q6h 6.
Baclofen 40mg PO qAM, 20mg PO q11am and q7pm 8.
Gabapentin 800mg PO TID 9.
Bactrim SS 1tab PO daily 13.
Bupropion SR 150mg PO daily 14.
Vitamin D3 400mg PO daily 15.
Morphine sulfate 90mg QAM, 90mg mid-day, 60mg QPM  Discharge Medications: 1. tobramycin sulfate 40 mg/mL Solution Sig: Three Hundred Seventy Five (375) mg Injection Q24H (every 24 hours): to be taken through [**4-27**].
Miralax 17 gram Powder in Packet Sig: One (1) dose PO once a day.
4. ferrous sulfate 325 mg (65 mg Iron) Tablet Sig: One (1) Tablet PO twice a day.
5. methadone 10 mg Tablet Sig: Five (5) Tablet PO TID (3 times a day).
6. ipratropium-albuterol 0.5 mg-3 mg(2.5 mg base)/3 mL Solution for Nebulization Sig: One (1) inhalation Inhalation every six (6) hours.
7. montelukast 10 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).
8. baclofen 10 mg Tablet Sig: Four (4) Tablet PO every morning.
9. baclofen 10 mg Tablet Sig: Two (2) Tablet PO BID (2 times a day): at 11am and 7pm.
10. gabapentin 400 mg Capsule Sig: Two (2) Capsule PO Q8H (every 8 hours).
11. omeprazole 20 mg Capsule, Delayed Release(E.C.)
12. testosterone 5 mg/24 hr Patch 24 hr Sig: One (1) Patch 24 hr Transdermal Q24H (every 24 hours).
13. lorazepam 1 mg Tablet Sig: One (1) Tablet PO HS (at bedtime) as needed for insomnia or anxiety.
Bactrim 400-80 mg Tablet Sig: One (1) Tablet PO once a day.
15. bupropion HCl 150 mg Tablet Extended Release Sig: One (1) Tablet Extended Release PO QAM (once a day (in the morning)).
16. cholecalciferol (vitamin D3) 400 unit Tablet Sig: One (1) Tablet PO twice a day.
17. calcium carbonate 200 mg (500 mg) Tablet, Chewable Sig: One (1) Tablet, Chewable PO BID (2 times a day).
18. morphine 30 mg Tablet Sig: Three (3) Tablet PO every morning.
19. morphine 30 mg Tablet Sig: Three (3) Tablet PO every day at noon.
20. morphine 30 mg Tablet Sig: Two (2) Tablet PO every evening.
Heparin Flush (10 units/ml) 2 mL IV PRN line flush PICC, heparin dependent: Flush with 10mL Normal Saline followed by Heparin as above daily and PRN per lumen.
Discharge Instructions: Mr. [**Known lastname 11622**], You were admitted with shortness of breath and chest discomfort and were found to have a pneumonia which we are treating with antibiotics.
We made the following changes to your medications: - STARTED tobramycin to be taken through [**2130-5-5**] - STARTED ceftazidime to be taken through [**2130-5-5**] .
